It has been about a month since the last earnings report for Steris (STE) . Shares have added about 2% in that time frame, underperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Steris due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers. STERIS Q4 Earnings Match Estimates, Margins Crash STERIS ...

AUSTIN, Texas, June 3, 2024 /PRNewswire/ -- An affiliate of Peak Rock Capital ("Peak Rock"), a leading middle-market private equity firm, announced today that it has completed the previously announced acquisition of the dental segment ("HuFriedyGroup" or the "Company") of STERIS plc (NYSE:STE) ("STERIS"). Founded in 1908, HuFriedyGroup is a leading global manufacturer of high-quality instruments, infection prevention products, instrument management systems, and conscious sedation products for the dental ind ...

United States Securities and Exchange Commission Washington, D. C. 20549 ________________________________________________ Commission file number 001-38848 STERIS plc (Exact name of registrant as specified in its charter) Ireland 98-1455064 FORM 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ For the fiscal year ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (State or other jurisdiction ...

Did you analyze how Steris (STE) fared in its international operations for the quarter ending March 2024? Given the widespread global presence of this medical products maker, scrutinizing the trends in international revenues becomes imperative to assess its financial strength and future growth possibilities. In the modern, closely-knit global economic landscape, the capacity of a business to access foreign markets is often a key determinant of its financial well-being and growth path. Investors now place gr ...

Capital expenditures for fiscal 2024 totaled $360 million, while depreciation and amortization totaled $565 million. Total debt sits at $3.2 billion and our total debt-to-EBITDA at quarter end was approximately 2.1 times gross leverage. Free cash flow for fiscal 2024 was $620 million as we benefited from higher generation from cash from operations, including less use of cash for working capital requirements. With that, I will turn the call over to Dan for his remarks. Dan Carestio Thanks Mike and good morni ...

STERIS plc (STE) reported fourth-quarter fiscal 2024 adjusted earnings per share (EPS) of $2.41, up 4.8% from the year-ago quarter’s figure. The figure matched the Zacks Consensus Estimate.The adjustment excludes the impacts of certain non-recurring charges like the amortization of acquired intangible assets and acquisition and integration-related charges, among others.The company’s GAAP net loss was 1 cent against the year-ago EPS of $1.88.  Revenues in DetailRevenues of $1.42 billion from continuing opera ...

Steris (STE) reported $1.42 billion in revenue for the quarter ended March 2024, representing a year-over-year increase of 2.5%. EPS of $2.41 for the same period compares to $2.30 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $1.46 billion, representing a surprise of -3.07%. The company has not delivered EPS surprise, with the consensus EPS estimate being $2.41.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compa ...

Steris (STE) came out with quarterly earnings of $2.41 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $2.30 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this medical products maker would post earnings of $2.17 per share when it actually produced earnings of $2.22, delivering a surprise of 2.30%.Over the last four quarters, the company has surpassed consensus EPS estimates two times.Steris, which belongs to th ...

Exhibit 99.1 STERIS Announces Financial Results for Fiscal 2024 Fourth Quarter and Full Year • Total fiscal 2024 revenue increase 12% to $5.5 billion • Total fiscal 2024 U.S. GAAP earnings per diluted share of $3.81; adjusted earnings per diluted share increase to $8.83 • Targeted restructuring plan announced DUBLIN, IRELAND - (May 8, 2024) - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 fourth quarter ended March 31, 2024. Total revenue for the fou ...

Total fiscal 2024 revenue increased 12% to $5.5 billionTotal fiscal 2024 U.S. GAAP earnings per diluted share of $3.81; adjusted earnings per diluted share increased to $8.83Targeted restructuring plan announced DUBLIN, IRELAND , May 08, 2024 (GLOBE NEWSWIRE) --  STERIS plc (NYSE:STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2024 fourth quarter ended March 31, 2024. Total revenue for the fourth quarter of fiscal 2024 increased 10% to $1.5 billion compared with $1.4 billio ...